Skip to content

Nuvation Bio NUVB Pre-Tax Income

Pre-Tax Income at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$3.24B+9.1%
Pfizer logo
PfizerPFE
$3.17B+13.8%
Nuvalent, Inc. logo
Nuvalent, Inc.NUVL
-$109.11M-29.2%
Arcus Biosciences logo
Arcus BiosciencesRCUS
-$128M-14.3%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$632.79M-387%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-$43.09M+7.1%

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's pre-tax income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvation Bio's pre-tax income?
Nuvation Bio (NUVB) reported pre-tax income of $5.4M in Q1 2026.
How has Nuvation Bio's pre-tax income changed year-over-year?
Nuvation Bio's pre-tax income increased by 110.1% year-over-year, from -$53.24M to $5.4M.
What is the long-term trend for Nuvation Bio's pre-tax income?
Over 4 years (2021 to 2025), Nuvation Bio's pre-tax income has grown at a 23.9% compound annual growth rate (CAGR), from -$86.85M to -$204.63M.
What does pre-tax income mean?
Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.